期刊文献+

FSH在上皮性卵巢肿瘤中的表达及意义 被引量:3

Expression and significance of FSH in epithelium ovarian tumor
下载PDF
导出
摘要 目的:研究卵泡刺激素(FSH)在良性、交界性、恶性上皮性卵巢肿瘤的表达。方法:放射免疫法对62例上皮性卵巢癌、30例交界性上皮性卵巢肿瘤及51例良性上皮性卵巢肿瘤患者血清及卵巢肿瘤组织液中的FSH进行测定。结果:FSH在卵巢癌患者血清和肿瘤组织液的表达(32.86mIU/ml,23.04mIU/ml)存在显著差异(P<0.05);在交界性上皮性卵巢肿瘤患者血清和肿瘤组织液的表达(36.29mIU/ml,29.12mIU/ml)存在显著差异(P<0.05);在良性上皮性卵巢肿瘤患者血清和肿瘤组织液的浓度表达(20.97mIU/ml,4.96mIU/ml)存在显著差异(P<0.01),在良性与恶性之间、良性与交界性之间FSH浓度均存在显著差异,且随着恶性程度的增高,FSH的浓度也呈增高趋势;而在交界性、恶性上皮性肿瘤组织液和血清中的浓度表达无明显统计学意义(P>0.05);I-II期与III-IV期卵巢癌患者血清和肿瘤组织液FSH表达无明显统计学意义(P>0.05)。结论:卵巢肿瘤组织中FSH表达升高可能与卵巢癌的发生有一定的关系。 Objective:To study the expression of follicleslimuiating hormone (FSH) in ovarian tumor. Methods: We measured the concentration of FSH in serum and tissue fluid of ovarian tumor. Results:There was a significant difference about concentration of FSH (36.29mIU/ml, 29. 12 mlU/ml) between serum and tissue fluid of ovarian cancer ( P 〈 0.05 ), and that ( 32.86mIU/m1,23.04 mIU/ml) between serum and tissue fluid of borderline tumor( P 〈 0.05 ), and that (20.97mIU/m1,4.96 mIU/ml ) between serum and tissue fluid of benign tumor( P 〈 0.01 ). There was also significant difference between malignant and benign tumor. FSH in malignat and borderline tumors was high- er than the others,while there was no significant difference about concentration of FSH between borderline tumor and benign tumor( P 〉 0. 05 ) and betweenⅠ - Ⅱ stage and Ⅲ- Ⅳ stage of ovarian cancer( P 〉 0.05 ). Conclusion : High expression of FSH may be related with ovarian carcinogenesis.
机构地区 陕西省人民医院
出处 《现代肿瘤医学》 CAS 2009年第5期927-928,共2页 Journal of Modern Oncology
关键词 卵泡刺激素 放射免疫 卵巢肿瘤 follicle stimulating hormone radioimmunity ovarian tumor
  • 相关文献

参考文献4

二级参考文献21

  • 1耿繁军 陈美凯.两种不同超排时间安排方案的效果比较.草食家畜,2003,:96-96.
  • 2Wang H,Mol Endocrinol,1992年,6卷,3期,320页
  • 3Cognie Y. State of the artin sheep-goat embryo transfer [J].Theriogenology, 1999,51(1):105-106.
  • 4Pintado B, Gutierrez-Adan A, Perez Llano B. Superovu latory response of murcian goats to treatments based on PMSG/anti-PMSG or combined FSH/PMSG administration [J]. Theriogenology, 1998, 50 (3): 357- 364.
  • 5Saharrea A, Valencia J, Balcazar A, et al. Pretreatment with recombinant bovine somatotropin enhances the superovulatory response to FSH in heifers[J].Theriogenology, 1998,50(7): 1039-1052.
  • 6Joyce I M, K halid M, Haresign W. Growth hormone priming as an adjunct treatment in superovulatory protocols in the ewe alters follicle development but has no effect on ovulationrate[J]. Theriogenology, 1998,50(6):873-884.
  • 7Fry R C ,Simpson T L, Squires T J. Ultrasonically guided transvaginal oocyte recovery from calves trea.ted with or without GnRH[J].Theriogenology,1999,49(6): 1077-1082.
  • 8桑润滋 田树军 李铁栓.影响波尔山羊超排效果因素的研究[J].草食家畜,2003,:83-87.
  • 9Venn A, Watson L, Bruinsma F, et al. Risk of cancer after use of fertility drugs with in vitro fertilization. Lancet, 1999, 354: 1586-1590.
  • 10Gnagy S, Ming EE, Devesa SS, et al. Declining ovarian cancer rates in U. S. women in relation to parity and oral contraceptive use. Epidemiology, 2000, 11 : 102-105.

共引文献38

同被引文献32

  • 1宋光辉,刘惜时.卵泡刺激素对上皮性卵巢癌细胞株的增殖及E-钙粘素表达的影响[J].实用妇产科杂志,2004,20(5):294-297. 被引量:4
  • 2曾泽毅.中华妇产科学[M].北京:人民卫生出版社, 1999.2 313.
  • 3黄妍,赵宇清,苏敏,高蜀君,金鸿雁,丰有吉.卵泡刺激素对卵巢癌细胞株增殖、凋亡和迁移侵袭的影响[J].中华医学杂志,2007,87(35):2512-2514. 被引量:7
  • 4Aoyama Y,Yamamoto Y,Yamaguchi F,Kitajima Y.Low to high Ca2+-switch causes phosphorylation and association of desmocollin 3 with plakoglobin and desmoglein 3 in cultured keratinocytes[J].Exp Derma-tol,2009,18:404-408.
  • 5Cui T,Chen Y,Yang L,Knosel T,ZNler K,Huber O,et al.DSC3 expression is regulated by p53,and methyl ation of DSC3 DNA is a prognostic marker in human colorectal cancer[J].Br J Cancer,2011,104:1013-1019.
  • 6Chen J,O' Shea C,Fitzpatrick J E,Koster M I,Koch P J.Loss of desmocollin 3 in skin tumor development and progression[J].Mol Carcinog,2012,51:535-545.
  • 7Wang L,Liu T,Wang Y,Cao L,Nishioka M,Aguirre R L,et al.Altered expression of desmocollin 3,desmo glein 3,and β-catenin in oral squamous cell carcinoma:correlation with lymph node metastasis and cell prolif-eration[J].Virchows Arch,2007,451:959-966.
  • 8Hamidov Z,Altendorf-Hofmann A,Chen Y,Settmacher U,Petersen I,Knosel T.Reduced expression of desmo-collin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocar-cinoma[J].J Clin Pathol,2011,64:990-994.
  • 9Monica V,Ceppi P,Righi L,Tavaglione V,Volante M,Pelosi G,et al.Desmocollin-3:a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung[J].Mod Pathol,2009,22:709-717.
  • 10Kolegraff K,Nava P,Helms M N,Parkos C A,Nus-rat A.Loss of desmocollin-2 confers a tumorigenic phe-notype to colonic epithelial cells through activation of Akt/β-catenin signaling[J].Mol Biol Cell,2011,22:1121-1134.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部